{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:56:09Z","timestamp":1764996969332},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T00:00:00Z","timestamp":1363046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s40262-013-0055-8","type":"journal-article","created":{"date-parts":[[2013,3,11]],"date-time":"2013-03-11T11:47:10Z","timestamp":1363002430000},"page":"647-656","source":"Crossref","is-referenced-by-count":12,"title":["A Review of the Pharmacokinetic Implications of Schistosomiasis"],"prefix":"10.1007","volume":"52","author":[{"given":"Kyle J.","family":"Wilby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel E.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary H. H.","family":"Ensom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,12]]},"reference":[{"key":"55_CR1","unstructured":"World Health Organization. Schistosomiasis Fact Sheet [online]. Available from URL: http:\/\/www.who.int\/mediacentre\/factsheets\/fs115\/en\/index.html [Accessed 2012 Sep 10]."},{"key":"55_CR2","unstructured":"USAID. Schistosomiasis [online]. Available from URL: http:\/\/transition.usaid.gov\/neglected_diseases\/target_diseases\/schistosomiasis\/index.html [Accessed 2012 Sep 10]."},{"key":"55_CR3","unstructured":"World Health Organization. Neglected Tropical Diseases [online]. Available from URL: http:\/\/www.who.int\/neglected_diseases\/diseases\/en\/ [Accessed 2012 Sep 10]."},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJMra012396","volume":"346","author":"AGP Ross","year":"2002","unstructured":"Ross AGP, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Eng J Med. 2002;346:1212\u201320.","journal-title":"N Eng J Med"},{"key":"55_CR5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/AAC.47.5.1487-1495.2003","volume":"47","author":"J Utzinger","year":"2003","unstructured":"Utzinger J, Keiser J, Shuhua X, et al. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother. 2003;47:1487\u201395.","journal-title":"Antimicrob Agents Chemother"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00003088-199937050-00004","volume":"37","author":"V Rodighiero","year":"1999","unstructured":"Rodighiero V. Effects of liver disease on pharmacokinetics. An update. Clin Pharmacokinet. 1999;37:399\u2013431.","journal-title":"Clin Pharmacokinet"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00003088-199121060-00004","volume":"21","author":"PO Gubbins","year":"1991","unstructured":"Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet. 1991;21:431\u201347.","journal-title":"Clin Pharmacokinet"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","volume":"65","author":"RK Verbeeck","year":"2009","unstructured":"Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009;65:757\u201373.","journal-title":"Eur J Clin Pharmacol"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/12.4.407","volume":"12","author":"JA Boscia","year":"1983","unstructured":"Boscia JA, Korzeniowski OM, Kobasa WD, et al. Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis. J Antimicrob Chemother. 1983;12:407\u201310.","journal-title":"J Antimicrob Chemother"},{"key":"55_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2125.1987.tb03187.x","volume":"24","author":"MMA Homeida","year":"1987","unstructured":"Homeida MMA, Ali HM, Arbab BMO, et al. Propranolol disposition in patients with hepatosplenic schistosomiasis. Br J Clin Pharmacol. 1987;24:393\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"55_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0035-9203(90)90333-A","volume":"84","author":"M Mandour","year":"1990","unstructured":"Mandour M, El Turabi H, Homeida MMA, et al. Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Trans R Soc Trop Med Hyg. 1990;84:389\u201393.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"55_CR12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/infdis\/157.3.530","volume":"157","author":"G Watt","year":"1988","unstructured":"Watt G, White NJ, Padre L, et al. Praziquantel pharmacokinetics and side effects in schistosoma japonicum-infected patients with liver disease. J Inf Dis. 1988;157:530\u20135.","journal-title":"J Inf Dis"},{"key":"55_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-8278(92)90008-D","volume":"15","author":"A Cukier","year":"1992","unstructured":"Cukier A, Strauss E. Terra Filho M, et al. Theophylline metabolism in patients with hepatosplenic mansoniasis and cirrhosis. J Hepatol. 1992;15:35\u20139.","journal-title":"J Hepatol"},{"key":"55_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gut.23.10.807","volume":"23","author":"TK Daneshmend","year":"1982","unstructured":"Daneshmend TK, Homeida M, Kaye CM, et al. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut. 1982;23:807\u201313.","journal-title":"Gut"},{"key":"55_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1995.tb05792.x","volume":"40","author":"MN Muscara","year":"1995","unstructured":"Muscara MN, Pedrazzoli J Jr, Miranda EL, et al. Plasma hydroxyl-metronidazole\/metronidazole ratio in patients with liver disease and in healthy volunteers. Br J Clin Pharmacol. 1995;40:477\u201380.","journal-title":"Br J Clin Pharmacol"},{"key":"55_CR16","first-page":"299","volume":"34","author":"G El-Azab","year":"1996","unstructured":"El-Azab G, Youssef MK, Higashi Y, et al. Acetaminophen plasma level after oral administration in liver cirrhotic patients suffering from schistosomal infection. Int J Clin Pharmacol Ther. 1996;34:299\u2013303.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"55_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5173(89)90319-0","volume":"53","author":"H El-Turabi","year":"1989","unstructured":"El-Turabi H, El-Sirag O, Homeida MMA, et al. Paracetamol pharmacokinetics in patients with hepatosplenic schistosomiasis. Int J Pharm. 1989;53:249\u201351.","journal-title":"Int J Pharm"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.1985.tb05069.x","volume":"20","author":"I El-Raghy","year":"1985","unstructured":"El-Raghy I, Back DJ, Osman F, et al. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis. Br J Clin Pharmacother. 1985;20:313\u20136.","journal-title":"Br J Clin Pharmacother"},{"key":"55_CR19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.19.9.808","volume":"19","author":"M Homeida","year":"1978","unstructured":"Homeida M, Salih SY, Branch RA. Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine. Gut. 1978;19:808\u201311.","journal-title":"Gut"},{"key":"55_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/19.1.87","volume":"19","author":"TK Daneshmend","year":"1987","unstructured":"Daneshmend TK, Homeida MA. Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan. J Antimicrob Chemother. 1987;19:87\u201393.","journal-title":"J Antimicrob Chemother"},{"key":"55_CR21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0010-7824(86)90099-5","volume":"33","author":"I El-Raghy","year":"1986","unstructured":"El-Raghy I, Back DJ, Osman F, et al. Contraceptive steroid concentrations in women with early active schistosomiasis: lack of effect of antischistosomal drugs. Contraception. 1986;33:373\u20137.","journal-title":"Contraception"},{"key":"55_CR22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.46.3.250","volume":"46","author":"RD Martins","year":"1993","unstructured":"Martins RD, Borges DR. Ethanol challenge in non-alcoholic patients with schistosomiasis. J Clin Pathol. 1993;46:250\u20133.","journal-title":"J Clin Pathol"},{"key":"55_CR23","volume-title":"Drug information handbook","author":"CF Lacy","year":"2011","unstructured":"Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook. 20th ed. Hudson: Lexi-Comp, Inc.; 2011.","edition":"20"},{"key":"55_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3347\/kjp.1979.17.1.67","volume":"17","author":"H Rim","year":"1979","unstructured":"Rim H, Park S, Lee J, et al. Therapeutic effects of praziquantal (Embay 8440 against Taenia solium infection. Korean J Parasitol. 1979;17:67\u201372.","journal-title":"Korean J Parasitol"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-013-0055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-013-0055-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-013-0055-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:03Z","timestamp":1559490063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-013-0055-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,12]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s40262-013-0055-8","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,12]]}}}